NSE filing, NSE: AVIENCE. Summary written from the filing by ALFA Finder's alert engine.
Avience Biomedicals Ltd: key numbers
- Share price
- ₹244.55
- Market cap
- ₹134.1 Cr
- Revenue (annual)
- ₹52.51 Cr
- Net profit (annual)
- ₹8.75 Cr
- P/E (TTM)
- 15.3×Sector 53.7×
- Promoter holding
- 64.59%
- FII holding
- 0.03%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Avience Biomedicals Ltd
All →Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.
Avience Biomedicals Other Announcement
Avience Biomedicals Limited has appointed M.A.M and Associates, GR Gupta & Associates, and V C A N & Co LLP as its statutory, secretarial, and internal auditors.
Avience Biomedicals Annual General Meeting
Avience Biomedicals Limited held its 7th AGM on September 30, 2026. Shareholders approved borrowing limits up to ₹100 Crore and the appointment of new statutory auditors.
Avience Biomedicals Annual General Meeting
Avience Biomedicals Limited has scheduled its 7th Annual General Meeting for September 30, 2026. The company also announced book closure dates for the AGM.
Avience Biomedicals Other Announcement
The company informed shareholders about accessing the 7th AGM Notice and Annual Report via web links and requested KYC updates for those with unregistered emails.
Avience Biomedicals Annual General Meeting
Avience Biomedicals filed notice of its 7th AGM, set for September 30, 2026, with its FY 2025-26 Annual Report. No monetary transaction is disclosed.
Other board meeting outcome announcements
All →Cubical Financial Services Board Meeting Outcome
Cubical Financial Services' board approved establishing a new corporate office in North Delhi. No monetary amount or capacity is stated.
Atmastco Board Meeting Outcome
Atmastco Limited's board approved the notice of its 32nd AGM on 25 November 2026, the FY2025-26 Annual Report, a scrutinizer and e-voting arrangements. No material business decision or monetary amount is reported.
Indrayani Biotech Board Meeting Outcome
Indrayani Biotech appointed Ms. N. S. Poornima as Secretarial Auditor for FY 2025-26 to fill a casual vacancy. Company Secretary C.S. Shanmuga Sundar's resignation took effect on 2 November 2026.
Borana Weaves Board Meeting Outcome
Borana Weaves' board approved shifting its registered office to Surat, Gujarat, effective immediately. The change is an administrative address update with no business impact.
Emergent Industrial Solutions Board Meeting Outcome
Emergent Industrial Solutions reconstituted its four board committees, reassigning existing directors across Audit, Nomination, Stakeholders Relationship, and CSR roles. This is routine governance with no financial impact.
Winsol Engineers Board Meeting Outcome
Winsol Engineers' board approved AoA changes to allow voluntary dividend waiver and postal ballot logistics. All decisions are routine governance matters with no material business impact.